tirzepatide china approval FDA Grants a New Indication for Obesity Management China approves Eli Lilly's blockbuster

The starting dose of semaglutide was 0.25 mg/week for 2 weeks, followed by 0.5 mg/week for 2 weeks, escalating to 1.0 mg/week for 12 weeks

MKK6 deficiency promotes cardiac dysfunction through MKK3-p38gamma/delta-mTOR hyperactivation

There are obesity treatment options beyond lifestyle changes and medication

DPP4 is an exopeptidase, which cleaves dipeptides from the penultimate N-terminal position of its substrates and thereby either inactivates these peptides and/or generates new bioactive compounds ( DPP4 expression and its regulation Dipeptidyl-peptidase 4 is ubiquitously expressed on numerous different cell types among which are epithelial cells, fibroblasts, and leukocyte subsets

Apr 2004;172(4):430-4

Low cholesterol concentrations and severe depressive symptoms in elderly people BMJ 1994